| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 01/15/2004 | US20040009984 Increasing levels of endogenous growth hormone, especially treating osterporosis, aging frailty or congestive heart failure |
| 01/15/2004 | US20040009983 Azaindoles |
| 01/15/2004 | US20040009981 Oxazole, thiazole, 1,3,4-oxadiazole and 1,3,4-thiadiazole derivatives of pyrimidines, 1,2,4- and 1,3,5-triazines |
| 01/15/2004 | US20040009978 Bicyclic or tricyclic fused pyrimidine derivatives or salts thereof which possess phosphatidylinositol 3 kinase (PI3K) inhibiting and antitumor activity |
| 01/15/2004 | US20040009977 For use in the prophylaxis and the treatment of Picornavirus and human rotavirus infections. |
| 01/15/2004 | US20040009974 Pyrimidylamino- or triazinylamino- substituted pyrazoles or 1,2,3-triazoles |
| 01/15/2004 | US20040009970 5HT2c agonists or partial agonists; e.g., 4,5,6,7,9a,10,11,12,13,13a-decahydro-9H-(1,4)diazepino-(6,7,1 -de)phenanthridine hydrochloride |
| 01/15/2004 | US20040009967 May contain further anticancer or immunosuppressive agents |
| 01/15/2004 | CA2492692A1 Charge transport compositions which are quinazoline derivatives and electronic devices made with such compositions |
| 01/15/2004 | CA2492690A1 Polymeric charge transport compositions and electronic devices made with such compositions |
| 01/15/2004 | CA2492689A1 Electronic devices made with electron transport and/or anti-quenching layers |
| 01/15/2004 | CA2492688A1 Charge transport compositions comprising fluorinated phenanthroline derivatives |
| 01/15/2004 | CA2492686A1 Charge transport compositions on the basis of triarylmethanes and their use in electronic devices |
| 01/15/2004 | CA2492122A1 Novel tricyclic spiropiperidines or spiropyrrolidines |
| 01/15/2004 | CA2491673A1 Naphthalimide synthesis including amonafide synthesis and pharmaceutical preparations thereof |
| 01/15/2004 | CA2491477A1 Indolin phenylsulfonamide derivatives |
| 01/15/2004 | CA2489166A1 Substituted anthranilic amide derivatives and methods of use |
| 01/15/2004 | CA2460051A1 7,8,9,10-tetrahydro-6h-azepino, 6,7,8,9-tetrahydro-pyrido and 2,3-dihydro-2h-pyrrolo[2,1-b]-quinazolinone derivatives |
| 01/14/2004 | EP1380585A1 Pyrazolopyridinone |
| 01/14/2004 | EP1380575A1 1,2-disubstituted 1,4-dihydro-4-oxoquinoline compounds |
| 01/14/2004 | EP1380298A2 Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders, anorexia, inflammation |
| 01/14/2004 | EP1380296A1 Hsp inductor |
| 01/14/2004 | EP1379618A1 Ligand and complex for catalytically bleaching a substrate |
| 01/14/2004 | EP1379527A1 Epindolidione pigments |
| 01/14/2004 | EP1379523A1 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin ii receptor antagonists |
| 01/14/2004 | EP1379520A1 N-substituted nonaryl-heterocyclic nmda/nr2b antagonists |
| 01/14/2004 | EP1379269A1 Adenosine a2a receptor antagonists combined with neurotrophic activity compounds in the treatment of parkinson's disease |
| 01/14/2004 | EP1379248A1 Tricyclic compounds useful as hiv reverse transcriptase inhibitors |
| 01/14/2004 | EP1379246A1 Nociceptin analogs |
| 01/14/2004 | EP1379245A1 1, 4, 5, 6-tetrahydropyrazolo- 3, 4-c]-pyrid in-7-ones as factor xa inhibitors |
| 01/14/2004 | EP1379244A1 1,4,5,6-tetrahydropyrazolo- 3,4-c]-pyridin-7-ones as factor xa inhibitors |
| 01/14/2004 | EP1379239A2 N-(2-arylethyl) benzylamines as antagonists of the 5-ht6 receptor |
| 01/14/2004 | EP1272491B1 Perylene-derivative based crystallization modifiers |
| 01/14/2004 | CN1468242A Azabicyclic compounds, preparation thereof and use as medicines, in particular as antibacterial agents |
| 01/14/2004 | CN1468241A Heterocyclic compounds as ligands of the gabaa receptor |
| 01/14/2004 | CN1468240A Derivatives of variolin b |
| 01/14/2004 | CN1468239A Substituted pyrazoles |
| 01/14/2004 | CN1468238A Substituted pyrazoles |
| 01/14/2004 | CN1468237A Substituted pyrazoles |
| 01/14/2004 | CN1468232A Heterocyclic sodium/proton exchange inhibitors and method |
| 01/14/2004 | CN1468227A Non-imidazole aryloxyalkylamines |
| 01/14/2004 | CN1468221A Non-imidazole aryloxypiperidines |
| 01/14/2004 | CN1468217A Aliphatic nitrogenous five-membered ring compounds |
| 01/14/2004 | CN1468216A Nitrogenous five-membered ring compounds |
| 01/14/2004 | CN1467208A [18F] Fluorin marked pyridine compound and method for preparing the same and uses as dopamine D4 receptor developer |
| 01/14/2004 | CN1134438C Bicyclic heteroaromatic compounds, method for prepearing the same and uses |
| 01/14/2004 | CN1134437C 5-substituted-3-oxadiazolyl-1,6-naphthyridin-2(1H)-ketone derivatives |
| 01/14/2004 | CN1134436C Pharmaceutically available protoberberine salt derivatives, and protoberberine derivatives and salt thereof |
| 01/13/2004 | US6677354 Treating sleep, brain, sexual, cardiovascular, nervous system, psychological, glandular, and gastrointestinal disorders |
| 01/13/2004 | US6677352 Non-insulin dependent, latent autoimmune, gestational diabetes treatment; impaired glucose tolerance; obesity, hypotensive agents |
| 01/13/2004 | US6677351 Useful in treatment of asthma and inflammation |
| 01/13/2004 | US6677349 Sulfonamide and sulfamide substituted imidazoquinolines |
| 01/13/2004 | US6677348 Aryl ether substituted imidazoquinolines |
| 01/13/2004 | US6677347 Anticarcinogenic and antitumor agents; viricided, immunomodulators |
| 01/13/2004 | US6677338 Serotonin transport inhibitors |
| 01/13/2004 | US6676909 Method for recovery of metals from metal-containing materials using medium temperature pressure leaching |
| 01/08/2004 | WO2004003599A2 Anisotropic films based on 1,8-naphthoylene-1',2'-benzimidazole sulfonates and lyotropic liquid crystal systems and methods for making |
| 01/08/2004 | WO2004002989A1 Process and intermediates for making non-nucleoside hiv-1 reverse transcriptase inhibitors |
| 01/08/2004 | WO2004002988A1 Improved method of making nevirapine |
| 01/08/2004 | WO2004002987A1 Spirosubstituted piperidines as selective melanin concentrating hormone receptor antagonists for the treatment of obesity |
| 01/08/2004 | WO2004002986A2 Novel benzimidazole derivatives |
| 01/08/2004 | WO2004002964A1 Diaminopyrimidinecarboxa mide derivative |
| 01/08/2004 | WO2004002531A1 Remedies for diseases caused by vascular contraction or dilation |
| 01/08/2004 | WO2004002492A1 Use of vasopeptidase inhibitors in the treatment of nephropathy |
| 01/08/2004 | WO2004002476A2 Fluorinated chlorin and bacteriochlorin photosensitizers for photodynamic therapy |
| 01/08/2004 | WO2004002468A1 Method of producing a cationic liposomal preparation comprising a lipophilic compound |
| 01/08/2004 | WO2004002454A1 Camptothecin-carboxylate formulations |
| 01/08/2004 | WO2003087088A3 (condensed) pyrimidone and (condensed) pyridone compounds, processes for their preparation, and pharmaceutical compositions containing them |
| 01/08/2004 | WO2003070166A3 Novel tyloindicines and related processes, pharmaceutical compositions and methods |
| 01/08/2004 | WO2003055856A3 BICYCLIC LACTAM DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES AND/OR TNF-α CONVERTING ENZYME (TACE) |
| 01/08/2004 | WO2002059124A3 Substituted pyrroloquinolines and pyridoquinolines as serotonin agonists and antagonists |
| 01/08/2004 | US20040006107 For prophylaxis of asthma and other allergic diseases |
| 01/08/2004 | US20040006101 Quinolinone derivatives |
| 01/08/2004 | US20040006098 Induce cytokine biosynthesis in animals |
| 01/08/2004 | US20040006096 Substituted alkanohydroxamic acids and method of reducing TNFalpha levels |
| 01/08/2004 | US20040006095 For therapy and prophylaxis of cardiovascular diseases, diabetes, diabetes- associated disorders, inflammatory diseases, immunological disorders, dermatological disorders, oncological disorders and central nervous system disorders |
| 01/08/2004 | US20040006090 Indole, azaindole and related heterocyclic sulfonylureido piperazine derivatives |
| 01/08/2004 | US20040006080 Chemical compounds |
| 01/08/2004 | US20040006079 Substituted 2,4-dihydro-pyrrolo[3,4-b]quinolin-9-one derivatives useful as phosphodiesterase inhibitors |
| 01/08/2004 | US20040006071 Non-nucleoside reverse transcriptase inhibitors |
| 01/08/2004 | US20040006067 Substituted piperidines and methods of use |
| 01/08/2004 | US20040006066 Ring fused pyrazole derivatives as CRF antagonists |
| 01/08/2004 | US20040006063 Dipeptide derivatives |
| 01/08/2004 | US20040006054 Cytotoxic N-unsubstituted indoles and cyclopent(b)indoles and method of making and using same |
| 01/08/2004 | US20040006047 Heterocyclic amides, a process for their preparation, compositions comprising them and their use |
| 01/08/2004 | US20040005637 Intermediate products coupled to solid polymeric support suitable for synthesis of heterocyclic compounds in simple and fast methods on solid phase; for synthesis of heterocycles with large structural diversity in high yields |
| 01/08/2004 | DE10227506A1 Ringsubstituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung Ring-substituted Diphenylazetidinones, processes for their preparation, pharmaceutical compositions containing them and their use |
| 01/08/2004 | DE10226943A1 Phenylaminopyrimidine und ihre Verwendung Phenylaminopyrimidine and their use |
| 01/08/2004 | CA2490692A1 Fluorinated chlorin and bacteriochlorin photosensitizers for photodynamic therapy |
| 01/08/2004 | CA2489555A1 Camptothecin-carboxylate formulations |
| 01/08/2004 | CA2487554A1 Process and intermediates for making non-nucleoside hiv-1 reverse transcriptase inhibitors |
| 01/07/2004 | EP1378510A1 Triazaspiro 5.5]undecane derivatives and drugs containing the same as the active ingredient |
| 01/07/2004 | EP1378509A1 Drugs containing triazaspiro 5.5]undecane derivatives as the active ingredient |
| 01/07/2004 | EP1378247A1 Visual function improving agents |
| 01/07/2004 | EP1378246A1 Remedies for arteriosclerosis |
| 01/07/2004 | EP1377971A1 Optical data carrier that contains a cationic aminoheterocyclic dye as the light-absorbing compound in the information layer |
| 01/07/2004 | EP1377970A1 Optical data carrier containing a cyclizable compound in the information layer |
| 01/07/2004 | EP1377583A1 Novel tricyclic hydroxy carboxamides and derivatives thereof; tocolytic oxytocin receptor antagonists |
| 01/07/2004 | EP1377581A1 Novel tricyclic pyridyl benzazepine carboxamides and derivatives thereof as tocolytic oxytocin receptor antagonists |
| 01/07/2004 | EP1377578A1 Beta-carboline derivatives and its pharmaceutical use against depression and anxiety |